To assess and validate the incorporation of the multiparametric magnetic resonance imaging (mpMRI) tumor stage (mT-stage) to the conventional clinical tumor stage (cT-stage), in order to guide the radiotherapy (RT) treatment decisions in prostate cancer. In addition, to identify the clinical factors associated to the technique reliability. 
Purpose or Objective:
To assess and validate the incorporation of the multiparametric magnetic resonance imaging (mpMRI) tumor stage (mT-stage) to the conventional clinical tumor stage (cT-stage), in order to guide the radiotherapy (RT) treatment decisions in prostate cancer. In addition, to identify the clinical factors associated to the technique reliability. Results: Three hund;red and fifty three patients at a median age of 70 years (range, 46 to 90) received SBRT. ADT was initiated prior to SBRT in 16% of patients and the median pre-
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